rs45592239

Variant summary

Our verdict is Benign. The variant received -13 ACMG points: 0P and 13B. BP4_StrongBP6BS1BS2

The NM_001089.3(ABCA3):​c.2296C>T​(p.Pro766Ser) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00214 in 1,614,026 control chromosomes in the GnomAD database, including 5 homozygotes. In-silico tool predicts a benign outcome for this variant. 15/22 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars). Synonymous variant affecting the same amino acid position (i.e. P766P) has been classified as Likely benign.

Frequency

Genomes: 𝑓 0.0017 ( 1 hom., cov: 32)
Exomes 𝑓: 0.0022 ( 4 hom. )

Consequence

ABCA3
NM_001089.3 missense

Scores

2
3
14

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications U:5B:2

Conservation

PhyloP100: 3.56

Publications

11 publications found
Variant links:
Genes affected
ABCA3 (HGNC:33): (ATP binding cassette subfamily A member 3) The membrane-associated protein encoded by this gene is a member of the superfamily of ATP-binding cassette (ABC) transporters. ABC proteins transport various molecules across extra- and intracellular membranes. ABC genes are divided into seven distinct subfamilies (ABC1, MDR/TAP, MRP, ALD, OABP, GCN20, White). This protein is a member of the ABC1 subfamily. Members of the ABC1 subfamily comprise the only major ABC subfamily found exclusively in multicellular eukaryotes. The full transporter encoded by this gene may be involved in development of resistance to xenobiotics and engulfment during programmed cell death. [provided by RefSeq, Jul 2008]
ABCA3 Gene-Disease associations (from GenCC):
  • interstitial lung disease due to ABCA3 deficiency
    Inheritance: AR Classification: STRONG, SUPPORTIVE Submitted by: Genomics England PanelApp, Labcorp Genetics (formerly Invitae), Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -13 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.010553002).
BP6
Variant 16-2295708-G-A is Benign according to our data. Variant chr16-2295708-G-A is described in ClinVar as Conflicting_classifications_of_pathogenicity. ClinVar VariationId is 178696.
BS1
Variant frequency is greater than expected in population nfe. GnomAd4 allele frequency = 0.00169 (258/152358) while in subpopulation NFE AF = 0.00329 (224/68030). AF 95% confidence interval is 0.00294. There are 1 homozygotes in GnomAd4. There are 104 alleles in the male GnomAd4 subpopulation. Median coverage is 32. This position passed quality control check.
BS2
High Homozygotes in GnomAdExome4 at 4 AR gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
ABCA3NM_001089.3 linkc.2296C>T p.Pro766Ser missense_variant Exon 18 of 33 ENST00000301732.10 NP_001080.2 Q99758-1Q4LE27

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
ABCA3ENST00000301732.10 linkc.2296C>T p.Pro766Ser missense_variant Exon 18 of 33 1 NM_001089.3 ENSP00000301732.5 Q99758-1
ABCA3ENST00000382381.7 linkc.2122C>T p.Pro708Ser missense_variant Exon 17 of 32 1 ENSP00000371818.3 H0Y3H2
ABCA3ENST00000563623.5 linkn.2859C>T non_coding_transcript_exon_variant Exon 18 of 20 1

Frequencies

GnomAD3 genomes
AF:
0.00167
AC:
255
AN:
152240
Hom.:
0
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.000458
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.000196
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00124
Gnomad FIN
AF:
0.000188
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.00329
Gnomad OTH
AF:
0.000478
GnomAD2 exomes
AF:
0.00171
AC:
429
AN:
251166
AF XY:
0.00179
show subpopulations
Gnomad AFR exome
AF:
0.000246
Gnomad AMR exome
AF:
0.000202
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.000139
Gnomad NFE exome
AF:
0.00338
Gnomad OTH exome
AF:
0.00130
GnomAD4 exome
AF:
0.00218
AC:
3193
AN:
1461668
Hom.:
4
Cov.:
32
AF XY:
0.00208
AC XY:
1515
AN XY:
727140
show subpopulations
African (AFR)
AF:
0.000209
AC:
7
AN:
33480
American (AMR)
AF:
0.000179
AC:
8
AN:
44724
Ashkenazi Jewish (ASJ)
AF:
0.000115
AC:
3
AN:
26136
East Asian (EAS)
AF:
0.00
AC:
0
AN:
39700
South Asian (SAS)
AF:
0.000951
AC:
82
AN:
86258
European-Finnish (FIN)
AF:
0.000320
AC:
17
AN:
53196
Middle Eastern (MID)
AF:
0.000173
AC:
1
AN:
5768
European-Non Finnish (NFE)
AF:
0.00266
AC:
2959
AN:
1112012
Other (OTH)
AF:
0.00192
AC:
116
AN:
60394
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.474
Heterozygous variant carriers
0
230
459
689
918
1148
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
104
208
312
416
520
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00169
AC:
258
AN:
152358
Hom.:
1
Cov.:
32
AF XY:
0.00140
AC XY:
104
AN XY:
74512
show subpopulations
African (AFR)
AF:
0.000457
AC:
19
AN:
41588
American (AMR)
AF:
0.000196
AC:
3
AN:
15308
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3472
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5184
South Asian (SAS)
AF:
0.00186
AC:
9
AN:
4830
European-Finnish (FIN)
AF:
0.000188
AC:
2
AN:
10628
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
0.00329
AC:
224
AN:
68030
Other (OTH)
AF:
0.000473
AC:
1
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.491
Heterozygous variant carriers
0
13
26
38
51
64
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
4
8
12
16
20
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00250
Hom.:
3
Bravo
AF:
0.00152
TwinsUK
AF:
0.00297
AC:
11
ALSPAC
AF:
0.00234
AC:
9
ESP6500AA
AF:
0.000227
AC:
1
ESP6500EA
AF:
0.00256
AC:
22
ExAC
AF:
0.00192
AC:
233
Asia WGS
AF:
0.000289
AC:
2
AN:
3478
EpiCase
AF:
0.00240
EpiControl
AF:
0.00261

ClinVar

Significance: Conflicting classifications of pathogenicity
Submissions summary: Uncertain:5Benign:2
Revision: criteria provided, conflicting classifications
LINK: link

Submissions by phenotype

Interstitial lung disease due to ABCA3 deficiency Uncertain:2
Apr 27, 2017
Illumina Laboratory Services, Illumina
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed as part of a predisposition screen in an ostensibly healthy population. A literature search was performed for the gene, cDNA change, and amino acid change (where applicable). No publications were found based on this search. Allele frequency data from public databases did not allow this variant to be ruled in or out of causing disease. Therefore, this variant is classified as a variant of unknown significance. -

Oct 28, 2019
Johns Hopkins Genomics, Johns Hopkins University
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This ABCA3 variant has been reported in the heterozygous state and as part of a complex allele with p.Leu960Phe. This patient does not carry the latter variant and the clinical significance of p.Pro766Ser alone is unclear. There are conflicting interpretations of the pathogenicity of this variant in ClinVar. One submitter classified it as a variant of uncertain clinical significance and one as likely benign. Of three bioinformatics tools queried, two predict that the substitution would be damaging, while one predicts that it would be tolerated. The proline residue at this position is highly evolutionarily conserved across most higher order species. Due to insufficient evidence, we consider the clinical significance of c.2296C>T to be uncertain at this time. -

not specified Uncertain:1Benign:1
Nov 05, 2014
Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Variant classified as Uncertain Significance - Favor Benign. The p.Pro766Ser var iant in ABCA3 has been reported in at least 10 individuals with various pulmonar y phenotypes (Baekvad-Hansen 2012). In addition, this variant has been identifie d in 0.26% (22/8600) of European American chromosomes by the NHLBI Exome Sequenc ing Project (http://evs.gs.washington.edu/EVS/; dbSNP rs45592239). Computational prediction tools and conservation analysis suggest that the p.Pro766Ser variant may not impact the protein, though this information is not predictive enough to rule out pathogenicity. In fact, 2 fish species (southern platyfish and spotted gar) carry a serine (Ser) at this position, suggesting that this change may be tolerated. In summary, while the clinical significance of the p.Pro766Ser varian t is uncertain, its frequency and the presence of the variant amino acid in othe r species suggests that it is more likely to be benign. -

Oct 14, 2016
Eurofins Ntd Llc (ga)
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not provided Uncertain:1Benign:1
Oct 12, 2024
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Jul 23, 2025
GeneDx
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Observed in the heterozygous state in four individuals with variable pulmnoary phenotypes including asthma, COPD, and interstitial lung disease, and in 121 patients from a general population health study (Copenhagen City Heart study) without a significant pulmonary phenotype, including one individual who was compound heterozygous for P766S and another missense variant (PMID: 22866751); In silico analysis supports that this missense variant has a deleterious effect on protein structure/function; This variant is associated with the following publications: (PMID: 35170262, 36808083, 24871971, 23625987, 22866751, 16641205, 34638622) -

Hereditary pulmonary alveolar proteinosis Uncertain:1
Jan 25, 2021
Ambry Genetics
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

The p.P766S variant (also known as c.2296C>T), located in coding exon 15 of the ABCA3 gene, results from a C to T substitution at nucleotide position 2296. The proline at codon 766 is replaced by serine, an amino acid with similar properties. This variant was identified in cis with p.L960F and in trans with a frameshift alteration in an infant with progressive lung disease and a histopathologic diagnosis of pulmonary alveolar proteinosis (Garmany TH et al. Pediatr. Res., 2006 Jun;59:801-5). In another study, the complex allele, p.[P766S; L960F], was identified in four individuals with severe pulmonary symptoms and a third ABCA3 alteration in trans (Wambach JA et al. Am. J. Respir. Crit. Care Med., 2014 Jun;189:1538-43). The p.P766S variant was identified in conjunction with two additional ABCA3 alterations in an individual with interstitial lung disease and chronic interstitial pneumonitis diagnosed at one year of age and a history of respiratory distress syndrome at birth; however, the phase of the alterations was not provided (Turcu S et al. Arch. Dis. Child., 2013 Jul;98:490-5).This amino acid position is not well conserved in available vertebrate species. In addition, this alteration is predicted to be tolerated by in silico analysis. Based on available evidence to date, the clinical significance of this variant remains unclear. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.11
BayesDel_addAF
Benign
-0.39
T
BayesDel_noAF
Benign
-0.34
CADD
Benign
21
DANN
Uncertain
1.0
DEOGEN2
Uncertain
0.68
D;.
Eigen
Benign
-0.066
Eigen_PC
Benign
0.091
FATHMM_MKL
Pathogenic
0.97
D
LIST_S2
Uncertain
0.87
D;D
M_CAP
Benign
0.029
D
MetaRNN
Benign
0.011
T;T
MetaSVM
Benign
-0.89
T
MutationAssessor
Benign
1.1
L;.
PhyloP100
3.6
PrimateAI
Benign
0.36
T
PROVEAN
Pathogenic
-5.6
D;D
REVEL
Benign
0.11
Sift
Benign
0.041
D;D
Sift4G
Benign
0.19
T;T
Polyphen
0.22
B;.
Vest4
0.30
MVP
0.71
MPC
0.27
ClinPred
0.044
T
GERP RS
4.7
Varity_R
0.25
gMVP
0.76
Mutation Taster
=88/12
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs45592239; hg19: chr16-2345709; API